Clinical Trials · NCT02518191

Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Xiangyun Zong
Enrollment
345
Start date
Sep 2015
Locations
2 sites, China
Primary endpoint
Number of Participants With Premature Ovarian Insufficiency
View Gonadorelin compound reference